NEOGENIX
"NEOGENIX" is a word mark owned by Neogenix Oncology, Inc., filed at the USPTO on September 30, 2010. It was cancelled and covers class 5 (Pharmaceuticals).
- Status
- Cancelled
- Since May 26, 2016
- Filed
- September 30, 2010
- Registered
- May 31, 2011
- Expires
- Not recorded
- Application no.
- 85141815
- Registration no.
- 3969998
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns NEOGENIX
The owner and representative on file with the office.
Owner
Neogenix Oncology, Inc.
Great Neck, United States
Representative
David L. May
What the mark covers
The products and services NEOGENIX is filed for, grouped by Nice class.
Diagnostic and therapeutic monoclonal antibodies, and vaccines, for the diagnosis and treatment of, and immunization to, cancers
What has happened so far
Steps recorded by the USPTO, newest first.
- Cancelled section 18-total
- Cancellation terminated no. 999999
- Cancellation granted no. 999999
- Cancellation instituted no. 999999
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Approved for pub - principal register
- Assigned to examiner
- New application office supplied data entered
1 earlier step on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About NEOGENIX
Who owns the trademark "NEOGENIX"?
The USPTO trademark "NEOGENIX" (application 85141815) is owned by Neogenix Oncology, Inc.
What is the status of "NEOGENIX"?
Its status at the USPTO is: cancelled.
When was "NEOGENIX" registered?
It was registered on May 31, 2011.
Get this data via the API
Everything on this page comes from the Signa API. Pull NEOGENIX and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2bc8-f9dd-708d-b88a-f66293edc4bb
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2bc8-f9dd-708d-b88a-f66293edc4bb",
"object": "trademark",
"mark_text": "NEOGENIX",
"status": {
"primary": "inactive",
"stage": "cancelled"
},
"office_code": "US",
"application_number": "85141815",
"filing_date": "2010-09-30",
"nice_classes": [
5
],
"owners": [
{
"name": "Neogenix Oncology, Inc.",
"entity_id": null
}
]
}